Evidence map›Paper›PMID 31328245›Full record

ReviewInternational journal of bipolar disorders2019

Clinical use of lithium salts: guide for users and prescribers.

Leonardo Tondo, Martin Alda, Michael Bauer, Veerle Bergink, Paul Grof, Tomas Hajek, Ute Lewitka, Rasmus W Licht, Mirko Manchia, Bruno Müller-Oerlinghausen and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of bipolar disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 199 citations in OpenAlex.

  1. The Efficacy of Pharmacological Treatment of Depression in Anorexia Nervosa and Underweight Patients: A Systematic Review.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 7 countries.

Leonardo TondoInternational Consortium for Research on Mood & Psychotic Disorders, McLean Hospital, Belmont, MA, USA. ltondo@aol.com.ORCID http://orcid.org/0000-0002-1624-0522
Martin AldaDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Michael BauerDepartment of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.
Veerle BerginkDepartment of Psychiatry and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, USA.
Paul GrofMood Disorders Center of Ottawa and Department of Psychiatry, University of Toronto, Toronto, Canada.
Tomas HajekDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Ute LewitkaDepartment of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.
Rasmus W LichtDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Mirko ManchiaDepartment of Pharmacology, Dalhousie University, Halifax, NS, Canada.
Bruno Müller-OerlinghausenDrug Commission of the German Medical Association, Berlin, Germany.
René E NielsenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Marylou SeloInternational Advocacy, New York, USA.
Christian SimhandlMedical Faculty, Bipolar Center, Sigmund Freud Private University, Wiener Neustadt, Austria.
Ross J BaldessariniInternational Consortium for Research on Mood & Psychotic Disorders, McLean Hospital, Belmont, MA, USA.
International Group for Studies of Lithium (IGSLi)
Dalhousie University · CAAalborg University Hospital · DKHarvard University · USSigmund Freud Privatuniversität Wien · ATErasmus MC · NLUniversity of Toronto · CA

Funding

Bruce Anderson 123456
6 · The paper itself

Abstract

backgroundLithium has been used clinically for 70 years, mainly to treat bipolar disorder. Competing treatments and exaggerated impressions about complexity and risks of lithium treatment have led to its declining use in some countries, encouraging this update about its safe clinical use. We conducted a nonsystematic review of recent research reports and developed consensus among international experts on the use of lithium to treat major mood disorders, aiming for a simple but authoritative guide for patients and prescribers. MAIN TEXT: We summarized recommendations concerning safe clinical use of lithium salts to treat major mood disorders, including indications, dosing, clinical monitoring, adverse effects and use in specific circumstances including during pregnancy and for the elderly.

conclusionsLithium continues as the standard and most extensively evaluated treatment for bipolar disorder, especially for long-term prophylaxis.

Indexed as

Bipolar disorderBlood testingDosingLithiumSide-effects

Identifiers

PMID31328245
PMCPMC6643006
OpenAlexW2963323531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.